إسرائيل - العبرية - Ministry of Health

teva pharmaceutical industries ltd, israel - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - vaginal fungal infections caused mainly by candida species. vaginal infections caused by trichomonas and microorganisms sensitive to clotrimazole.

إسرائيل - العبرية - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - vaginal fungal infections caused mainly by candida species. vaginal infections caused by trichomonas and microorganisms sensitive to clotrimazole.

إسرائيل - العبرية - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

إسرائيل - العبرية - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

إسرائيل - العبرية - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

إسرائيل - العبرية - Ministry of Health

salomon,levin & elstein ltd - cefonicide as sodium - אבקה להכנת תמיסה לזריקה - cefonicide as sodium 1000 mg/vial - cefonicide - cefonicide - treatment of serious bacterial infections caused by microorganisms susceptible to cefonicid. studies on specimens obtained prior to therapy should be used to determine the susceptibility or the causative organisms to cefonicid.therapy with cefonicid may be initiated pending results of the studies however.treatment should be adjusted according to study findings. cefonicid-teva is indicated in the treatment of the infections of the lower respiratory tract urinary tract skin and skin structure bone and joints. in the treatment of the above-mentioned infections the product is particularly used in weak and/or immuno-depressed patients. surgical prophylaxis: the administration of a single 1 g. dose of cefonicid-teva before surgery may reduce the incidence of post-operative infections caused by susceptible microorganisms in patients undergoing surgical procedures classified as contaminated or potentially contaminated or in patients in whom infection at the operative site would present a serious risk providing protec

إسرائيل - العبرية - Ministry of Health

abic ltd. - ofloxacin - טבליה - ofloxacin 200 mg - ofloxacin - ofloxacin - bacterial infections due to ofloxacin-susceptible microorganisms, such as:- acute, chronic, or recurrent lower respiratory tract infections (bronchitis) pneumonia (not for the treatment of first choice in pnemonia caused by pneumococci). - chronic and recurrent infections of the ear, nose, and throat. ofloxacin is in general not indicated for the treatment of acute tonsillitis caused by betahaemolytic streptococci. - infections of soft tissues and skin. - infections of the bones and joints. - abdominal infections including infections in the pelvis minor and bacterial enteritis. - infections of the kidney, urinary tract, and genital organs, gonorrhoea.prevention of infections due to ofloxacin-susceptible pathogens in patients with a significant reduction in resistance to infections (e.g. in neutropenic state).

إسرائيل - العبرية - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

إسرائيل - العبرية - Ministry of Health

bayer israel ltd - moxifloxacin - תמיסה לאינפוזיה - moxifloxacin 400 mg / 250 ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

إسرائيل - العبرية - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - rifabutin - קפסולות - rifabutin 150 mg - rifabutin - rifabutin - for the treatment of chronic tuberculosis where there is evidence of acid fast bacteria resistant to rifampicin or to two other alternative drugs. for the treatment of infections caused by mac or other atypical mycobacteria where there is evidence of resistant bacteria as above. for the treatment of infections caused by mac or other atypical mycobacteria in aids patients in all cases not subject to the above restrictions. for prevention of mac infections in aids patients whose cd4 counts lower or eqval to 200/mm3